BKNG · Booking Holdings Inc.

The thesis

Booking Holdings closed at $147.94 on 28 October 2026, 32.2% below its 52-week high of $218.11, and the Q3 2026 report on 3 November 2026 decides whether the sell-off reflects a business problem or a fear about AI. Operating results through Q2 are intact; the shares are being priced on what AI agents, regulators and analysts say may happen next.

The close is below the $150 invalidation level in the previous note and below the 2 October 2026 adjusted close of $159.02. Since then the European Commission opened Digital Services Act (DSA) proceedings against Booking.com (21 October 2026), Jefferies cut its target to $185 from $200 (19 October 2026), and Baird cut its target to $223 from $230 (27 October 2026).

Q2 2026 room nights rose 5% to 325 million and revenue rose 8% to $7.4 billion (Q2 earnings release, 4 August 2026). Guidance for Q3 is revenue growth of 4% to 6% and room-night growth of 3% to 5%. The narrative is accelerating on the downside: new regulatory and AI headlines arrived on 21 October 2026, and the 3-month price change is -23.1%.

The view is wrong on the upside if Q3 room nights grow 5% or more and the shares close a week above $188, the level of Bernstein's target.

Bullish and bearish views on Booking Holdings Inc.

The bull case on Booking Holdings Inc. (BKNG), in brief: Management calls AI referrals small. The bear case: The price has broken lower again.

Bull case

• Management calls AI referrals small. An executive said on the 4 August 2026 call that AI-driven referrals remain a relatively small contributor (Benzinga). The Q3 call is the next test of that statement.
• Buyback capacity is large against a lower price. Booking repurchased $3.7 billion of stock in Q2 and had $14.5 billion of authorization remaining at 30 June 2026 (Q2 earnings release).
• Many analysts keep high targets. BTIG reiterated Buy with a $250 target on 22 October 2026, Baird holds a $223 target after its 27 October 2026 cut, and Bank of America maintained its Buy rating on 26 October 2026 (Benzinga).
• Selling is stretched. The 14-day relative strength index (RSI) was 33.9 on 28 October 2026, close to the oversold zone below 30 (adjusted daily closes). It reached 26.7 on 2 October 2026.

Bear case

• The price has broken lower again. The 28 October 2026 close of $147.94 is under both the $150 level and the 2 October 2026 close of $159.02, so the October low is no longer holding (adjusted daily closes).
• AI agents threaten the aggregator model. Bernstein rates the shares Market Perform with a $188 target, citing risk to take rates (Benzinga, 26 August 2026). Booking announced a $100 million investment in an AI travel agent called Vayo (Benzinga, 14 October 2026), and Benzinga reported on 21 October 2026 on a trade that favors hotel stocks over online agencies.
• Regulatory pressure now has two fronts. The European Commission opened DSA proceedings on 21 October 2026 over fraudulent listings, phishing and unlabelled paid listings; a breach can bring a fine of up to 6% of annual worldwide turnover. Reuters reported on 7 October 2026 that the US Federal Trade Commission (FTC) is preparing action over affiliate hotel ads, with one source citing penalties above $500 million.
• Targets keep coming down. Jefferies cut to $185 from $200 on 19 October 2026, Cantor Fitzgerald cut its Neutral target to $170 on 12 October 2026, and Wells Fargo cut its Equal-Weight target to $190 on 7 October 2026 (Benzinga).
• The Q3 comparison is hard. Hudson Labs' earnings preview says Q3 2025 had double-digit growth across major measures, and that long-haul travel faces pressure from the Middle East conflict.

Price setup

The shares closed at $147.94 on 28 October 2026, against a 52-week high of $218.11. The 3-month change is -23.1% and the 14-day RSI is 33.9 (adjusted daily closes). The shares sit well under their recent trading range, so no wide gap above a rising moving average is visible.

Crowding evidence points to heavy attention rather than heavy buying. The earnings date is five sessions away, headline flow on AI and regulators is dense, and target cuts are frequent. CFO Steenbergen's Rule 10b5-1 sales plan, adopted 13 May 2026, runs through 31 March 2027, so Form 4 filings inside that window are pre-scheduled.

Earnings previews put Q3 consensus earnings per share between $4.42 and $4.54, depending on the source (Hudson Labs, Earnings Whispers, Benzinga). The previews differ on revenue, so the guided 4% to 6% growth range is the cleaner yardstick.

Catalysts, next 30 days

• The report tests room-night and revenue guidance, the Q3 repurchase pace and any figure for AI-driven referrals.
• Undated: The European Commission's DSA proceedings and a possible FTC complaint have no announced date. Either could land at any time.

What would change the view

The case breaks to the downside if the shares close below $140 or if the Q3 report shows revenue growth under 4% or room-night growth under 3%, which would put the business below its own guidance. A filed FTC complaint, or an accrual near the reported $500 million, would add a separate cost.

The case improves if Q3 room nights grow 5% or more, management shows AI referrals staying small, and the shares hold a weekly close above $188. Further target cuts before 3 November 2026 would show analysts moving toward the lower end of the range.

What it trades with

Booking trades with Expedia and other online travel agencies on AI-agent news. Reports on 1 October 2026 said Expedia partnered with Meta's Muse agent and Booking did not. Expedia's Q2 2026 gross bookings grew 12% against Booking's 9%.

Large-cap consumer discretionary shares share some of the macro exposure.